One-way ANOVA and Tukey’s multiple comparison tests at the four CpG islands showed significantly lower methylation in the CpG islands of the TOX3 promoter in luminal A and B breast tumors compared to normal breast tissues and basal-like breast tumors (Fig 4C). The gene discussed is TOX3; the disease is breast neoplasm.